Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00189228
Status:
COMPLETED
Last Update Posted:
2019-09-27
First Post:
2005-09-10
Brief Title:
Immune Dysfunction in Allergic Asthma
Sponsor:
University of New Mexico
Organization:
University of New Mexico
Study Overview
Official Title:
Not a Drug Trial We Are Using Anti-IgE to Examine the Role of Pulmonary Mast Cells in Asthma
Status:
COMPLETED
Status Verified Date:
2019-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
We are using anti-IgE to investigate the role of pulmonary mast cells in asthma
Detailed Description:
Subjects with mild allergic asthma are examined before immediately after and 2 months after a course of treatment with anti-IgE The following are examined Allergen skin tests allergen induced asthma peripheral blood basophils pulmonary bronchial mucosal mast cells
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01HL044253 | NIH | None | httpsreporternihgovquickSearchR01HL044253 |